secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptevo Therapeutics Inc. (APVO)
CIK:        0001671584
Form:       8-K
Filed at:   2025-12-29T23:59:59+00:00
Accession:  0001193125-25-335497
Event type: other
Sentiment:  negative
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptevo Therapeutics files 1-for-18 reverse stock split effective Dec 29, 2025
-----------------------------------------------------------------------------

- Reverse split ratio 1-for-18 approved by board Dec 17; effective Dec 29 at 5:01 PM ET.
- Split-adjusted trading on Nasdaq begins Dec 30; new CUSIP 03835L702.
- No fractional shares issued; cash in lieu; adjustments to options, warrants, RSUs.
- Stockholders approved split on July 24, 2025 Special Meeting; range 1:6–1:22.
- Forward-looking statements acknowledge risk of ability to continue as going concern.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671584/000119312525335497/0001193125-25-335497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671584/000119312525335497/apvo-20251229.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-335497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer